Metcrusaders.org

Clinical Trial Overview

WEBThe principal investigator (PI) is the person in charge of the trial. He or she is a scientist who’s an expert in what the clinical trial is about. The PI takes the lead in designing the …

Actived: 5 days ago

URL: https://metcrusaders.org/clinical-trials/clinical-trial-overview/

Dr. Ross Camidge, M.D., Ph.D.

WEBAppointment Number: 720-848-9264. Following a PhD in Molecular Biology at the Medical Research Council’s Laboratory of Molecular Biology at Cambridge University, UK, Dr …

Category:  Medical Go Health

Your resource or the latest research into the MET alteration.

WEB4 Q2 2021 RESEARCH EDITION A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP …

Category:  Cancer Go Health

Clinical Trial Search

WEBHow to Find a Clinical Trial. There are three ways of finding a clinical trial. The first is to ask your doctor. The second is to use a clinical trial search engine. The third is to enlist an …

Category:  Health Go Health

Research & Publication Team

WEBThe MET Crusaders’ Research and Publication Team is a group of practicing scientific and medical professionals dedicated to patient advocacy. They attend major symposiums …

Category:  Medical Go Health

Your resource for the latest research into the MET alteration.

WEB4 Q3 2021 RESEARCH EDITION • The KRAS-mutant group was the largest group, and no difference was seen between different KRAS- mutant alleles (G12C, G12D, G12V) • In …

Category:  Health Go Health

Your resource for the latest research into the MET alteration.

WEBMET Crusaders does not verify or validate the quality of the materials offered. If you are a researcher with a METex14 or other MET mutated cell line, and you would be willing to …

Category:  Health Go Health

Jessica McKernan, PharmD, BCOP

WEBJessica is a clinical oncology pharmacist who has been working with cancer patients and physicians for almost five years. She is passionate about empowering patients to be …

Category:  Cancer Go Health

Laura Schmidt, PharmD, BCOP

WEBLaura completed her Pharm.D. at Midwestern University Chicago College of Pharmacy in 2015. She completed both her PGY1 and PGY2 residency training in …

Category:  Health Go Health

Your resource for the latest research into the MET alteration.

WEB6. CRUSADER NEWSLETTER ESMO, TARGETED THERAPIES, ASCO EDITION. TKI TRIALS. NIH Identifier: NCT04084717. Link: https://clinicaltrials.gov/ct2/ …

Category:  Health Go Health

N E W S L E T T E R

WEBN E W S L E T T E R. Your resource for the latest research into the MET alteration. CRUSADER. In this edition. Contact us at. [email protected]. NOVEMBER 2020 …

Category:  Health Go Health

Your resource or the test research into the ET ltertion. CRUADER

WEB2. Q1 2021 RESEARCH EDITION. Long-term efficacy of immune checkpoint inhibitors in non-small . cell lung cancer patients harboring . MET. exon 14 skipping mutations

Category:  Cancer Go Health

You esource o the test esearch into the ET ltertion. CRUSADER

WEBYou esource o the test esearch into the ET ltertion. N E W S L E T T E R CRUSADER Contact us at In this edition [email protected] Q4 2021 RESEARCH EDITION …

Category:  Health Go Health

Emmeline Academia, PharmD, BCOP

WEBEmmeline Academia, PharmD is a Clinical Pharmacy Specialist at Beth Israel Deaconess Medical Center in Boston, Massachusetts. She completed her PharmD at the University …

Category:  Medical Go Health

N E W S L E T T E R

WEBSafety. • Common side effects: peripheral edema (51%), nausea (45%), vomiting (28%) • Grade 3-4 side effects: peripheral edema (9%), labored breathing (7%), fatigue (6%) …

Category:  Health Go Health

Molecular mechanisms of acquired resistance to MET tyrosine …

WEB3 1 amplification and KRAS mutations) were detected. Switching between type I and type II 2 MET inhibitors resulted in partial responses in two patients. The understanding of the 3 …

Category:  Health Go Health